Security key
09061G101
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 192,632,743
- Total 13F shares
- 179,472,067
- Share change
- -4,698,076
- Total reported value
- $9,720,162,187
- Put/Call ratio
- 65%
- Price per share
- $54.16
- Number of holders
- 572
- Value change
- -$257,275,980
- Number of buys
- 295
- Number of sells
- 271
Report period
Q3 2025
Institutions
572
Top holders
10
BMRN full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
BIOMARIN PHARMACEUTICAL INC SEC filings
BIOMARIN PHARMACEUTICAL INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09061G101
Recent filing periods:
Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ |
13D/G
13F
|
Company |
8.2%
|
15,795,383
|
$906,812,938 | $0 | 30 Jun 2025 | |
| Capital Research Global Investors |
13D/G
13F
|
Company |
4.8%
|
9,150,655
|
$576,308,252 | -$241,913,549 | 31 Mar 2025 | |
| VIKING GLOBAL INVESTORS LP |
13F
13D/G
|
Company |
4.3%
from 13D/G
|
12,288,611
|
$675,504,947 | — | 30 Jun 2025 | |
| Robert J. Hombach |
3/4/5
|
Director |
0.02%
|
41,870
|
$2,636,972 | — | 20 May 2025 | |
| Willard H. Dere |
3/4/5
|
Director |
0.02%
|
38,950
|
$2,453,071 | — | 20 May 2025 | |
| Elizabeth M. Anderson |
3/4/5
|
Director |
0.02%
|
34,450
|
$2,169,661 | — | 20 May 2025 | |
| Maykin Ho |
3/4/5
|
Director |
0.01%
|
28,010
|
$1,764,069 | — | 20 May 2025 | |
| Barbara W. Bodem |
3/4/5
|
Director |
0.01%
|
13,555
|
$853,693 | — | 20 May 2025 | |
| Athena Countouriotis |
3/4/5
|
Director |
0.01%
|
13,550
|
$853,379 | — | 20 May 2025 | |
| Mark J. Enyedy |
3/4/5
|
Director |
0.01%
|
13,550
|
$853,379 | — | 20 May 2025 | |
| Timothy P. Walbert |
3/4/5
|
Director |
0.01%
|
10,196
|
$642,143 | — | 20 May 2025 | |
| Ian T. Clark |
3/4/5
|
Director |
0%
|
7,000
|
$401,870 | — | 01 Aug 2025 | |
| BlackRock, Inc. |
13F
|
Company |
12%
|
24,001,675
|
$1,319,372,049 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.9%
|
19,003,832
|
$1,044,640,645 | — | 30 Jun 2025 | |
| DODGE & COX |
13F
|
Company |
7.8%
|
15,108,310
|
$830,503,801 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.6%
|
8,847,751
|
$486,360,872 | — | 30 Jun 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.9%
|
5,580,573
|
$306,429,231 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
3,474,438
|
$190,416,616 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.5%
|
2,834,355
|
$155,804,494 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
2,428,689
|
$133,505,190 | — | 30 Jun 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.1%
|
2,161,172
|
$118,679,120 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
2,105,605
|
$115,745,118 | — | 30 Jun 2025 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
2,043,879
|
$112,352,029 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.94%
|
1,806,771
|
$99,318,202 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.88%
|
1,695,593
|
$93,206,747 | — | 30 Jun 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.87%
|
1,672,447
|
$91,934,412 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.86%
|
1,655,111
|
$90,981,451 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.82%
|
1,573,620
|
$86,506,895 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.81%
|
1,556,117
|
$85,539,751 | — | 30 Jun 2025 | |
| Man Group plc |
13F
|
Company |
0.77%
|
1,476,922
|
$81,186,402 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.71%
|
1,365,581
|
$75,065,975 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.69%
|
1,319,792
|
$72,548,967 | — | 30 Jun 2025 | |
| DnB Asset Management AS |
13F
|
Company |
0.58%
|
1,119,330
|
$61,529,570 | — | 30 Jun 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.58%
|
1,115,428
|
$61,315,077 | — | 30 Jun 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.57%
|
1,093,378
|
$60,142,981 | — | 30 Jun 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.55%
|
1,062,818
|
$58,423,103 | — | 30 Jun 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.54%
|
1,039,484
|
$57,140,435 | — | 30 Jun 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.53%
|
1,022,309
|
$56,196,326 | — | 30 Jun 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.51%
|
983,048
|
$54,038,149 | — | 30 Jun 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.47%
|
902,304
|
$49,599,651 | — | 30 Jun 2025 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
0.47%
|
897,516
|
$49,336,442 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.46%
|
888,029
|
$48,814,954 | — | 30 Jun 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
0.44%
|
840,470
|
$46,200,636 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.42%
|
801,471
|
$44,056,847 | — | 30 Jun 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.38%
|
738,482
|
$40,594,400 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.38%
|
736,885
|
$40,506,568 | — | 30 Jun 2025 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.38%
|
733,166
|
$40,302,135 | — | 30 Jun 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.38%
|
726,814
|
$39,952,966 | — | 30 Jun 2025 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.37%
|
717,682
|
$39,451,000 | — | 30 Jun 2025 | |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ |
13F
|
Company |
0.37%
|
713,846
|
$39,240,115 | — | 30 Jun 2025 |
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q3 2025
As of 30 Sep 2025,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
572 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
179,472,067 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, Dodge & Cox, STATE STREET CORP, VIKING GLOBAL INVESTORS LP, AQR CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, and Capital Research Global Investors.
This page lists
574
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
576
Q3 2025 holders
572
Holder diff
-4
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.